Unity Biotechnology, Inc. (0YC0.L) LSE

0.06

+0(+0.00%)

Updated at September 05 04:59PM

Currency In USD

Valuation

Market Cap16.43M
Enterprise Value32.39M
P/E Ratio-0.12
PEG Ratio0.02
Price/Sales Ratio2.59
Price/Book Ratio-16.47
Enterprise/Revenue13.59
Enterprise/EBITDA-0.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-20.71
Operating Margin-20.95

Management Effectiveness

Return On Assets-0.91
Return On Equity-2.74

Income Statement

Revenue0
Revenue/Share0.08
Gross Profit-867,000
EBITDA-25.12M
Net Income-25.99M
Diluted EPS-1.54

Balance Sheet

Total Cash16.93M
Total Cash/Share1
Total Debt22.61M
Total Debt/Equity-110.28
Current Ratio1.95
Book Value Per Share-0.01

Price History

52-Week Change-95.64
52-Week High3.79
52-Week Low0.06
Moving Average 50 Days1.83
Moving Average 200 Days2.31

Statistics

Average Volume551
Shares Outstanding17.21M
% Held by Institutions14.95

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 30, 2023